237 related articles for article (PubMed ID: 26446085)
41. SMCHD1 is involved in de novo methylation of the DUX4-encoding D4Z4 macrosatellite.
Dion C; Roche S; Laberthonnière C; Broucqsault N; Mariot V; Xue S; Gurzau AD; Nowak A; Gordon CT; Gaillard MC; El-Yazidi C; Thomas M; Schlupp-Robaglia A; Missirian C; Malan V; Ratbi L; Sefiani A; Wollnik B; Binetruy B; Salort Campana E; Attarian S; Bernard R; Nguyen K; Amiel J; Dumonceaux J; Murphy JM; Déjardin J; Blewitt ME; Reversade B; Robin JD; Magdinier F
Nucleic Acids Res; 2019 Apr; 47(6):2822-2839. PubMed ID: 30698748
[TBL] [Abstract][Full Text] [Related]
42. Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy in Patients Clinically Suspected of FSHD Using Optical Genome Mapping.
Guruju NM; Jump V; Lemmers R; Van Der Maarel S; Liu R; Nallamilli BR; Shenoy S; Chaubey A; Koppikar P; Rose R; Khadilkar S; Hegde M
Neurol Genet; 2023 Dec; 9(6):e200107. PubMed ID: 38021397
[TBL] [Abstract][Full Text] [Related]
43. Facioscapulohumeral muscular dystrophy type 2: an update on the clinical, genetic, and molecular findings.
Jia FF; Drew AP; Nicholson GA; Corbett A; Kumar KR
Neuromuscul Disord; 2021 Nov; 31(11):1101-1112. PubMed ID: 34711481
[TBL] [Abstract][Full Text] [Related]
44. Facioscapulohumeral muscular dystrophy.
Tawil R
Handb Clin Neurol; 2018; 148():541-548. PubMed ID: 29478599
[TBL] [Abstract][Full Text] [Related]
45. Mutations in DNMT3B Modify Epigenetic Repression of the D4Z4 Repeat and the Penetrance of Facioscapulohumeral Dystrophy.
van den Boogaard ML; Lemmers RJLF; Balog J; Wohlgemuth M; Auranen M; Mitsuhashi S; van der Vliet PJ; Straasheijm KR; van den Akker RFP; Kriek M; Laurense-Bik MEY; Raz V; van Ostaijen-Ten Dam MM; Hansson KBM; van der Kooi EL; Kiuru-Enari S; Udd B; van Tol MJD; Nishino I; Tawil R; Tapscott SJ; van Engelen BGM; van der Maarel SM
Am J Hum Genet; 2016 May; 98(5):1020-1029. PubMed ID: 27153398
[TBL] [Abstract][Full Text] [Related]
46. Allele-specific DNA hypomethylation characterises FSHD1 and FSHD2.
Calandra P; Cascino I; Lemmers RJ; Galluzzi G; Teveroni E; Monforte M; Tasca G; Ricci E; Moretti F; van der Maarel SM; Deidda G
J Med Genet; 2016 May; 53(5):348-55. PubMed ID: 26831754
[TBL] [Abstract][Full Text] [Related]
47. Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy.
Jones TI; King OD; Himeda CL; Homma S; Chen JC; Beermann ML; Yan C; Emerson CP; Miller JB; Wagner KR; Jones PL
Clin Epigenetics; 2015; 7(1):37. PubMed ID: 25904990
[TBL] [Abstract][Full Text] [Related]
48. Methylation of the 4q35 D4Z4 repeat defines disease status in facioscapulohumeral muscular dystrophy.
Erdmann H; Scharf F; Gehling S; Benet-Pagès A; Jakubiczka S; Becker K; Seipelt M; Kleefeld F; Knop KC; Prott EC; Hiebeler M; Montagnese F; Gläser D; Vorgerd M; Hagenacker T; Walter MC; Reilich P; Neuhann T; Zenker M; Holinski-Feder E; Schoser B; Abicht A
Brain; 2023 Apr; 146(4):1388-1402. PubMed ID: 36100962
[TBL] [Abstract][Full Text] [Related]
49. [Facioscapulohumeral muscular dystrophy type 2].
Sacconi S; Desnuelle C
Rev Neurol (Paris); 2013; 169(8-9):564-72. PubMed ID: 23969240
[TBL] [Abstract][Full Text] [Related]
50. Cross-sectional Neuromuscular Phenotyping Study of Patients With Arhinia With
Mohassel P; Chang N; Inoue K; Delaney A; Hu Y; Donkervoort S; Saade D; Billioux BJ; Meader B; Volochayev R; Konersman CG; Kaindl AM; Cho CH; Russell B; Rodriguez A; Foster KW; Foley AR; Moore SA; Jones PL; Bonnemann CG; Jones T; Shaw ND
Neurology; 2022 Mar; 98(13):e1384-e1396. PubMed ID: 35121673
[TBL] [Abstract][Full Text] [Related]
51. Identification of variants in the 4q35 gene FAT1 in patients with a facioscapulohumeral dystrophy-like phenotype.
Puppo F; Dionnet E; Gaillard MC; Gaildrat P; Castro C; Vovan C; Bertaux K; Bernard R; Attarian S; Goto K; Nishino I; Hayashi Y; Magdinier F; Krahn M; Helmbacher F; Bartoli M; Lévy N
Hum Mutat; 2015 Apr; 36(4):443-53. PubMed ID: 25615407
[TBL] [Abstract][Full Text] [Related]
52. Facioscapulohumeral muscular dystrophy (FSHD) molecular diagnosis: from traditional technology to the NGS era.
Zampatti S; Colantoni L; Strafella C; Galota RM; Caputo V; Campoli G; Pagliaroli G; Carboni S; Mela J; Peconi C; Gambardella S; Cascella R; Giardina E
Neurogenetics; 2019 May; 20(2):57-64. PubMed ID: 30911870
[TBL] [Abstract][Full Text] [Related]
53. Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing.
Jones TI; Yan C; Sapp PC; McKenna-Yasek D; Kang PB; Quinn C; Salameh JS; King OD; Jones PL
Clin Epigenetics; 2014; 6(1):23. PubMed ID: 25400706
[TBL] [Abstract][Full Text] [Related]
54. Identification of SMCHD1 domains for nuclear localization, homo-dimerization, and protein cleavage.
Hiramuki Y; Tapscott SJ
Skelet Muscle; 2018 Aug; 8(1):24. PubMed ID: 30071896
[TBL] [Abstract][Full Text] [Related]
55. Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy.
Greco A; Goossens R; van Engelen B; van der Maarel SM
Clin Genet; 2020 Jun; 97(6):799-814. PubMed ID: 32086799
[TBL] [Abstract][Full Text] [Related]
56. DNMT3B splicing dysregulation mediated by SMCHD1 loss contributes to DUX4 overexpression and FSHD pathogenesis.
Engal E; Sharma A; Aviel U; Taqatqa N; Juster S; Jaffe-Herman S; Bentata M; Geminder O; Gershon A; Lewis R; Kay G; Hecht M; Epsztejn-Litman S; Gotkine M; Mouly V; Eiges R; Salton M; Drier Y
Sci Adv; 2024 May; 10(22):eadn7732. PubMed ID: 38809976
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of Optical Genome Mapping in Clinical Genetic Testing of Facioscapulohumeral Muscular Dystrophy.
Kovanda A; Lovrečić L; Rudolf G; Babic Bozovic I; Jaklič H; Leonardis L; Peterlin B
Genes (Basel); 2023 Nov; 14(12):. PubMed ID: 38136988
[TBL] [Abstract][Full Text] [Related]
58. Deep characterization of a common D4Z4 variant identifies biallelic DUX4 expression as a modifier for disease penetrance in FSHD2.
Lemmers RJ; van der Vliet PJ; Balog J; Goeman JJ; Arindrarto W; Krom YD; Straasheijm KR; Debipersad RD; Özel G; Sowden J; Snider L; Mul K; Sacconi S; van Engelen B; Tapscott SJ; Tawil R; van der Maarel SM
Eur J Hum Genet; 2018 Jan; 26(1):94-106. PubMed ID: 29162933
[TBL] [Abstract][Full Text] [Related]
59. Clinical features of facioscapulohumeral muscular dystrophy 2.
de Greef JC; Lemmers RJ; Camaño P; Day JW; Sacconi S; Dunand M; van Engelen BG; Kiuru-Enari S; Padberg GW; Rosa AL; Desnuelle C; Spuler S; Tarnopolsky M; Venance SL; Frants RR; van der Maarel SM; Tawil R
Neurology; 2010 Oct; 75(17):1548-54. PubMed ID: 20975055
[TBL] [Abstract][Full Text] [Related]
60. Patients with a phenotype consistent with facioscapulohumeral muscular dystrophy display genetic and epigenetic heterogeneity.
Sacconi S; Camaño P; de Greef JC; Lemmers RJ; Salviati L; Boileau P; Lopez de Munain Arregui A; van der Maarel SM; Desnuelle C
J Med Genet; 2012 Jan; 49(1):41-6. PubMed ID: 21984748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
